You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -2,654.2% | 0.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 258.1 | 9.4 |
| Price / Book value | 4.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 14.3% | -53.7% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 88.9% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-05-31 | 1.34 | -2.01 | -8.67p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-05-31 | 0.43 | -9.01 | -12.97p | -10.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-05-31 | 1.50 | 0.00 | -16.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-05-31 | 6.60 | 0.00 | -11.20p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-05-31 | 14.10 | 0.00 | -1.40p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Oncimmune Holdings' loss deepens on spiralling costs Sharecast News | 13 Feb |
|---|---|
| Oncimmune buoyed by US distribution deal for blood tests Sharecast News | 20 Dec |
| Oncimmune signs sales deals in multiple countries for 'EarlyCDT-Lung' test Sharecast News | 28 Nov |
| Half Year Results | 13-Feb-19 07:04 |
|---|---|
| Notice of Half Year Results | 31-Jan-19 07:09 |
| Grant of Options and PDMR notification | 24-Jan-19 07:04 |
| Oncimmune appoints new Scientific Board | 13-Dec-18 07:02 |
| Senior Leadership Team Appointments & Board Change | 06-Dec-18 16:35 |